Photo via The Independent

More new US moms are taking GLP-1 drugs

Read the original at The Independent ↗
Cite

Musto, J. (2026, October 1). More new US moms are taking GLP-1 drugs. The Independent. https://www.independent.co.uk/news/health/us-mothers-glp1-drugs-diabetes-weight-loss-b3059985.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

The Independent · collected 2026-10-01 · by Julia Musto

Quick Summary

Researchers at the University of Southern California report that prescriptions for GLP-1 diabetes and weight loss medications among new mothers in the U.S. have increased 24-fold over seven years, from 0.8% to 1.9%. The study, based on insurance claims data for over one million births, shows a significant rise among women with gestational diabetes, particularly those who are obese or overweight before pregnancy. Lead author Sih-Ting Cai emphasizes the need for further research given the limited evidence on GLP-1 use during breastfeeding and its effects postpartum.
Written by AI on 2026-10-01, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

University of Southern California researchers have found that the percentage of new mothers receiving prescriptions for GLP-1 drugs, which are used to treat diabetes and promote weight loss, increased 24-fold over seven years. The study, based on insurance claims data from over one million births, shows this figure rose from just 0.8 percent in the first half of 2018 to 1.9 percent by the first quarter of 2025.

Lead author and Schaeffer scholar Sih-Ting Cai emphasized that postpartum is a crucial period for addressing metabolic risks after pregnancy, noting an "explosion" in GLP-1 use among new mothers. However, she highlighted that evidence regarding the effects of these drugs during breastfeeding remains limited, warranting further investigation into their safety and efficacy in this context.

Written for “GLP-1 Drug Use Rising Among New Moms” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.

Story

📰 GLP-1 Drug Use Rising Among New Moms
Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 18% of its claims. Each row says how that neighbour differs.
New York Post
Hedges 2 of 25 claims Outlet record 66/100
“Article A focuses specifically on new mothers receiving GLP-1 drugs after giving birth, while Article B discusses broader use among US adults for weight loss.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
17
sentences that state something as happening or true
Uncertain
18%
3 of 17 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
59/100
The Independent's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-01 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Independent · 3569 article(s) · 9 correction(s) detected
Running correction rate · 9 correction(s)

Who wrote this

Julia Musto
38 article(s) here · 1 carrying a prediction
🔮 While over 50 million Americans have voted in this year’s midterm elections, millions more will head to the polls on Tuesday.
🔮 Bird flu has yet to spread from human to human, but experts are worried that the mutating virus could transform.
🔮 “We have worried this would increase rates of problem gambling among youth.
🔮 “It takes about two weeks for the body to build protection, and getting vaccinated now will help provide protection for the holiday season when people gather indoors,” Juthani said.
🔮 Busy California airports used by millions of travelers could face flooding risks during the upcoming holiday season thanks to sea level rise and a record-breaking El Niño climate pattern, a new report warns.
🔮 Spreading cases in mink could help the virus mutate enough to make that transition.
🔮 The weather could be downright frightful in parts of the U.S. this Halloween as kids and families head out for trick-or-treating.
🔮 The threat is projected to worsen with researchers projecting 317,000 annual deaths from superbugs in North America by 2050.
🔮 If you have a sore throat right now, it might not be a cold or the onset of the flu.
🔮 So the longer your house remains at the lower temperature, the more energy you save, because your house has lost less energy than it would have at the higher temperature,” the department says.
Also by Julia Musto
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 38 articles by Julia Musto →

Topics

American Denmark Independent the Centers for Disease Control and Prevention the University of Southern California

Subjects

American NORP · 1× Americans NORP · 1× Denmark GPE · 1× Harvard T.H. Chan School of Public Health ORG · 1× Independent ORG · 1× Jyoti Manekar PERSON · 1× Schaeffer PERSON · 1× Sih-Ting Cai PERSON · 1× the Centers for Disease Control and Prevention ORG · 1× the University of Southern California ORG · 1×

Narrative

“Postpartum is a critical window for addressing metabolic risk after pregnancy, and we're seeing GLP-1 use explode in this population,” lead author and Schaeffer scholar Sih-Ting Cai explained in a statement. “Because evidence on GLP-1 exposure during breastfeeding remains limited, rising postpartum initiation warrants further study,” she said.
framing: assertive · carried by 1 article(s) · first seen 2026-10-01
🔮 The condition typically goes away after the baby is born, but raises the risk of developing type 2 diabetes and may increase the risk of postpartum depression, the Centers for Disease Control and Prevention shows.
2026-10-01 · The Independent
More new US moms are taking GLP-1 drugs · assertive framing

Claims (17 extracted, 3 hedged)

More American moms are being prescribed GLP-1 diabetes and weight loss medications after they give birth, first-of-its-kind research published Thursday shows. asserted
research → prescribe → kind
The percentage of new mothers receiving prescriptions for the drugs saw a 24-fold increase over the course of seven years, researchers at the University of Southern California found. asserted
researchers → receive → California
Insurance claims data for over one million births revealed the percentage ticked up from just 0.8 percent in the first half of 2018 to 1.9 percent by the first quarter of 2025. uncertain
percentage → reveal → 2025
But while the drugs have been shown to benefit multiple facets of health in years of research, the effects of the drugs postpartum have not been studied widely. asserted
effects → show → drugs
“Postpartum is a critical window for addressing metabolic risk after pregnancy, and we're seeing GLP-1 use explode in this population,” lead author and Schaeffer scholar Sih-Ting Cai explained in a statement. “Because evidence on GLP-1 exposure during breastfeeding remains limited, rising postpartum initiation warrants further study,” she said. asserted
she → address → study
A major jump for moms with gestational diabetes This study is one of the first to document this surge and also the first to identify which clinical groups – women with diabetes, gestational diabetes, obesity or no documented diagnosis – are driving the growth. asserted
groups → document → growth
Most mothers started taking the drug between 3-6 months after their delivery. asserted
mothers → start → delivery
Mothers with type 2 diabetes had the highest rate of prescriptions, and prescribing increased the quickest among those diagnosed as obese or overweight before their pregnancy. asserted
prescribing → have → pregnancy
The share of those with gestational diabetes – a type of diabetes that forms during pregnancy – starting GLP-1 drugs also rose substantially from 0.4 percent in mid-2021 to 2.7 percent in the first quarter of 2025. asserted
that → form → 2025
Gestational diabetes affects between 5-9 percent of pregnancies. asserted
diabetes → affect → pregnancies
The condition typically goes away after the baby is born, but raises the risk of developing type 2 diabetes and may increase the risk of postpartum depression, the Centers for Disease Control and Prevention shows. uncertain
Centers → go → Control
The authors said the observed uptick was similar to rates in Denmark, as reported in a separate study last year. asserted
uptick → say → study
The study further reveals how the popularity of the medications has exploded since the early 2020s, with more than 30 million Americans now taking GLP-1s. asserted
Americans → reveal → GLP-1s
However, data regarding taking GLP-1 drugs during breastfeeding remains scant. asserted
data → regard → breastfeeding
Taking the drugs during the first trimester does not appear to substantially increase the risk of adverse outcomes, a June study led by Harvard T.H. Chan School of Public Health found. asserted
study → take → Health
But the medications are still not recommended during the postpartum period for breastfeeding mothers, Dr. Jyoti Manekar, an obesity medicine specialist at Georgia’s Northside Hospital healthcare system, said in a post 2025. asserted
Manekar → recommend → post
“There’s limited safety data in lactating women, and it's unclear whether the drug is excreted in breast milk or how it might affect a nursing infant’s growth, metabolism or pancreatic development,” she explained. uncertain
she → ’ → growth
💬Give feedback
🕘History 🎫Support